122 related articles for article (PubMed ID: 26856481)
1. Perceived cognitive changes with chemotherapy for breast cancer: A pilot study.
Piacentine LB; Miller JF; Haberlein S; Bloom AS
Appl Nurs Res; 2016 Feb; 29():9-11. PubMed ID: 26856481
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.
Payne J; Piper B; Rabinowitz I; Zimmerman B
Oncol Nurs Forum; 2006 Jul; 33(4):775-83. PubMed ID: 16858459
[TBL] [Abstract][Full Text] [Related]
3. Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue.
Li J; Yu L; Long Z; Li Y; Cao F
Psychooncology; 2015 Jun; 24(6):676-82. PubMed ID: 25345397
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
5. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
[TBL] [Abstract][Full Text] [Related]
6. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and cognitive complaints in women with breast cancer.
Pullens MJ; De Vries J; Van Warmerdam LJ; Van De Wal MA; Roukema JA
Psychooncology; 2013 Aug; 22(8):1783-9. PubMed ID: 23109296
[TBL] [Abstract][Full Text] [Related]
9. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
11. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion.
Henneghan A; Stuifbergen A; Becker H; Kesler S; King E
J Cancer Surviv; 2018 Apr; 12(2):224-233. PubMed ID: 29116555
[TBL] [Abstract][Full Text] [Related]
12. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
13. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
15. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
16. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study.
Berger AM; Higginbotham P
Oncol Nurs Forum; 2000 Oct; 27(9):1443-8. PubMed ID: 11058976
[TBL] [Abstract][Full Text] [Related]
17. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.
Klemp JR; Myers JS; Fabian CJ; Kimler BF; Khan QJ; Sereika SM; Stanton AL
Support Care Cancer; 2018 Feb; 26(2):575-583. PubMed ID: 28849337
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.
Byar KL; Berger AM; Bakken SL; Cetak MA
Oncol Nurs Forum; 2006 Jan; 33(1):E18-26. PubMed ID: 16470230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]